Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | |
Nov. 30, 2013 | Mar. 13, 2014 | |
Document And Entity Information | ' | ' |
Entity Registrant Name | 'Purthanol Resources Ltd | ' |
Entity Central Index Key | '0001126162 | ' |
Document Type | '10-K | ' |
Document Period End Date | 30-Nov-13 | ' |
Amendment Flag | 'true | ' |
Amendment description | 'This amendment is for the sole purpose of filing the XBRL financial report. | ' |
Current Fiscal Year End Date | '--11-30 | ' |
Is Entity a Well-known Seasoned Issuer? | 'No | ' |
Is Entity a Voluntary Filer? | 'No | ' |
Is Entity's Reporting Status Current? | 'Yes | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Public Float | ' | $2,776,858 |
Entity Common Stock, Shares Outstanding | ' | 185,123,890 |
Document Fiscal Period Focus | 'FY | ' |
Document Fiscal Year Focus | '2013 | ' |
Balance_Sheets
Balance Sheets (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
CURRENT ASSETS | ' | ' |
Cash | $114 | $7 |
Prepaid Expenses | 0 | 95,581 |
Notes Receivable | 122,200 | 0 |
Short Term Investments | 197,448 | 198,160 |
Total Current Assets | 319,762 | 293,748 |
Property & Equipment (Net) | ' | 86,430 |
Intangible Assets | 700,000 | ' |
TOTAL ASSETS | 1,019,762 | 380,178 |
CURRENT LIABILITIES | ' | ' |
Bank Overdraft | ' | ' |
Accounts Payable | 974,854 | 972,551 |
Notes Payable - (Related Party) | 45,244 | 46,352 |
Notes Payable | 1,286,231 | 1,248,156 |
Total Current Liabilities | 2,306,329 | 2,267,059 |
STOCKHOLDERS EQUITY | ' | ' |
Preferred Stock $0.0001 par value, Authorized 80,000,000 shares, 0 shares issued and outstanding as of November 30, 2013 and November 30, 2012 | ' | ' |
Common Stock $0.0001 par value, 260,000,000 shares authorized: 164,473,890 shares issued and outstanding as of November 30, 2013 and 82,073,890 as of November 30, 2012 | 16,447 | 8,207 |
Paid-in capital | 2,795,550 | 1,667,790 |
Deficit accumulated during the development stage | -4,098,564 | -3,562,878 |
Total Stocksholders Equity | -1,286,567 | -1,886,881 |
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $1,019,762 | $380,178 |
Balance_Sheets_Parenthetical
Balance Sheets (Parenthetical) (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
Statement of Financial Position [Abstract] | ' | ' |
Preferred stock authorized shares | 80,000,000 | 80,000,000 |
Preferred stock par value shares | $0.00 | $0.00 |
Preferred stock shares issued | 0 | 0 |
Preferred stock shares outstanding | 0 | 0 |
Common stock authorized shares | 260,000,000 | 260,000,000 |
Common stock par value shares | $0.00 | $0.00 |
Common stock shares issued | 164,473,890 | 82,073,890 |
Common stock shares outstanding | 164,473,890 | 82,073,890 |
Statements_of_Operations
Statements of Operations (USD $) | 12 Months Ended | 181 Months Ended | |
Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2013 | |
Income Statement [Abstract] | ' | ' | ' |
REVENUES | $312,200 | ' | $1,257,011 |
Cost of revenues | ' | ' | ' |
GROSS PROFIT | 312,200 | ' | 653,948 |
OPERATING COSTS | ' | ' | ' |
Bad debt expense | ' | ' | 120,844 |
Licensing rights | ' | ' | 700,000 |
Depreciation expense | ' | ' | 73,274 |
Marketing expense | ' | ' | 236,266 |
Professional fees | 15,000 | 11,000 | 240,295 |
Selling, general and administrative expense | 671,388 | 215,875 | 2,403,119 |
Total operating costs | 686,388 | 226,875 | 3,773,795 |
OPERATING (LOSS) | -374,188 | -226,875 | -3,119,850 |
OTHER INCOME & (EXPENSES) | ' | ' | ' |
Fx | 30,787 | -20,304 | -18,419 |
Interest income | 9,608 | 9,148 | 146,797 |
Other income (net) | ' | ' | 85,005 |
Interest expense | -69,755 | -68,505 | -578,493 |
Write-down of leasehold improvements | ' | ' | -2,663 |
Write-up of notes receivable, related parties | ' | ' | 11,435 |
Impairment Loss | -132,138 | -86,428 | -981,969 |
Gain on sale of investment | ' | ' | 359,583 |
Total Other Income & (Expenses) | -161,498 | -166,089 | -978,714 |
NET INCOME (LOSS) | ($535,686) | ($392,964) | ($4,098,564) |
BASIC EARNINGS (LOSS) PER SHARE | $0 | $0 | ' |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | 99,842,657 | 82,073,890 | ' |
Statements_of_Cash_Flows
Statements of Cash Flows (USD $) | 12 Months Ended | 181 Months Ended | |
Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2013 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' | ' |
NET INCOME (LOSS) | ($535,686) | ($392,964) | ($4,098,564) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' | ' |
Depreciation expense | ' | ' | 73,274 |
Common stock issued for services | 436,000 | ' | 872,143 |
Gain on sale of Investment | ' | ' | -359,583 |
Impairment Loss | 132,138 | 86,428 | 981,969 |
Write-down of leasehold improvements | ' | ' | -2,663 |
Write-down of notes receivable | ' | ' | 11,435 |
Accrued interest expense - note payable | 69,755 | 68,505 | 469,005 |
Accrued interest income - notes receivable | -9,608 | -9,148 | -141,271 |
Changes in operating assets and liabilities: | ' | ' | ' |
(Increase) decrease in accounts receivable & prepaids | 49,873 | 49,868 | -45,708 |
(Increase) decrease in notes receivable | -111,880 | -6,009 | -578,068 |
Increase (decrease) in accounts payable | 2,303 | 179,650 | 974,854 |
Net Cash Provided by (Used in) Operating Activities | 32,895 | -23,670 | -1,860,721 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' | ' |
Net sale (purchase) of fixed assets | ' | ' | -60,937 |
Purchase of short term investments | ' | ' | -168,560 |
Proceeds from sale of investment shares | ' | ' | 489,061 |
Net Cash Provided by (Used in) Investing Activities | ' | ' | 259,564 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' | ' |
Issuance of common stock | ' | ' | 156,262 |
Payment of common stock subscription receivable | ' | ' | 206,239 |
Proceeds from-(payment) notes payable | -32,788 | 23,668 | 1,238,770 |
Net Cash Provided by (Used in) Financing Activities | -32,788 | -2 | 1,601,271 |
Net Increase (Decrease) in Cash | 107 | 9 | 114 |
Cash at Beginning of Year | 7 | ' | ' |
Cash at End of Year | 114 | 7 | 114 |
Supplemental Cash Flow Disclosures: | ' | ' | ' |
Cash paid during period for interest | ' | ' | ' |
Cash paid during period for taxes | ' | ' | ' |
Non-Cash flows activities | ' | ' | ' |
Shares issued for Intangible Assets | 700,000 | ' | 700,000 |
Shares issued for Property & Equipment | ' | ' | 600,000 |
Shares issued for Goodwill | ' | ' | 115,000 |
Note receivable -related party offset with Note payable | ' | ' | 181,878 |
Note receivable exchanged for Goodwill | ' | ' | $216,261 |
Shareholders_Equity
Shareholders Equity (USD $) | Common Stock | Additional Paid-In Capital | Stock Subscription Receivable | (Deficit) Accumulated During the Development Stage | Total |
Beginning Balance, Value at Nov. 30, 1998 | ' | ' | ' | ' | ' |
Beginning Balance, Shares at Nov. 30, 1998 | 0 | ' | ' | ' | ' |
Rounding | ' | ' | ' | ' | ' |
Stock issued for cash, Shares | 10,400,000 | ' | ' | ' | ' |
Stock issued for cash, Value | 1,040 | 258,961 | -103,739 | ' | 156,262 |
Stock issued for equipment purchase, Shares | 600,000 | ' | ' | ' | ' |
Stock issued for equipment purchase, Value | 60 | 14,940 | ' | ' | 15,000 |
Stock issued in exchange for shares of Millenia Hope, Inc., Shares | 35,700,000 | ' | ' | ' | ' |
Stock issued in exchange for shares of Millenia Hope, Inc., Value | 3,570 | 125,908 | ' | ' | 129,478 |
Stock issued in exchange for notes payable, Shares | ' | ' | ' | ' | ' |
Collection on subscription | ' | ' | 103,739 | ' | 103,739 |
NET INCOME (LOSS) | ' | ' | ' | -69,231 | -69,231 |
Ending Balance, Value at Nov. 30, 2000 | 4,670 | 399,809 | ' | -69,231 | 335,248 |
Ending Balance, Shares at Nov. 30, 2000 | 46,700,000 | ' | ' | ' | ' |
Rounding | ' | ' | ' | ' | ' |
Stock issued for cash, Shares | 410,000 | ' | ' | ' | ' |
Stock issued for cash, Value | 41 | 309,959 | -310,000 | ' | ' |
Stock issued in exchange for notes payable, Shares | ' | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -1,679 | -1,679 |
Ending Balance, Value at Nov. 30, 2001 | 4,711 | 709,768 | -310,000 | -70,910 | 333,569 |
Ending Balance, Shares at Nov. 30, 2001 | 47,110,000 | ' | ' | ' | ' |
Rounding | ' | ' | ' | ' | ' |
Stock issued for payment of consulting fees, Shares | 92,500 | ' | ' | ' | ' |
Stock issued for payment of consulting fees, Value | 9 | 18,491 | ' | ' | 18,500 |
Stock issued in exchange for professional fees, Shares | 205,200 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | 21 | 51,354 | ' | ' | 51,375 |
Stock issued in exchange for notes payable, Shares | ' | ' | ' | ' | ' |
Collection on subscription | ' | -207,500 | 207,500 | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -141,693 | -141,693 |
Ending Balance, Value at Nov. 30, 2002 | 4,741 | 572,113 | -102,500 | -212,603 | 261,751 |
Ending Balance, Shares at Nov. 30, 2002 | 47,407,700 | ' | ' | ' | ' |
Rounding | 300 | ' | ' | ' | ' |
Stock issued in exchange for marketing expense, Shares | 600,000 | ' | ' | ' | ' |
Stock issued in exchange for marketing expense, Value | 60 | 42,440 | ' | ' | 42,500 |
Stock issued in exchange for notes payable, Shares | 257,500 | ' | ' | ' | ' |
Stock issued in exchange for notes payable, Value | 26 | 12,849 | ' | ' | 12,875 |
Collection on subscription | ' | ' | 102,500 | ' | 102,500 |
NET INCOME (LOSS) | ' | ' | ' | -715,903 | -715,903 |
Ending Balance, Value at Nov. 30, 2003 | 4,827 | 627,402 | ' | -928,506 | -296,277 |
Ending Balance, Shares at Nov. 30, 2003 | 48,265,500 | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -12,936 | -12,936 |
Ending Balance, Value at Nov. 30, 2004 | 4,827 | 627,402 | ' | -941,469 | -309,240 |
Ending Balance, Shares at Nov. 30, 2004 | 48,265,500 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | ' | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | 142,417 | 142,417 |
Ending Balance, Value at Nov. 30, 2005 | 4,827 | 627,402 | ' | -799,052 | -166,823 |
Beginning Balance, Shares at Nov. 30, 2005 | 48,265,500 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Shares | 1,000,000 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | 100 | 900 | ' | ' | 1,000 |
NET INCOME (LOSS) | ' | ' | ' | -47,203 | -47,203 |
Ending Balance, Value at Nov. 30, 2006 | 4,927 | 628,302 | ' | -846,255 | -213,026 |
Ending Balance, Shares at Nov. 30, 2006 | 49,265,500 | ' | ' | ' | ' |
Stock issued for equipment purchase, Shares | 18,000,000 | ' | ' | ' | ' |
Stock issued for equipment purchase, Value | 1,800 | 718,200 | ' | ' | 720,000 |
NET INCOME (LOSS) | ' | ' | ' | -376,336 | -376,336 |
Ending Balance, Value at Nov. 30, 2007 | 6,727 | 1,346,502 | ' | -1,222,591 | 130,638 |
Ending Balance, Shares at Nov. 30, 2007 | 67,265,500 | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -63,371 | -63,371 |
Ending Balance, Value at Nov. 30, 2008 | 6,727 | 1,346,502 | ' | -1,285,962 | 67,267 |
Ending Balance, Shares at Nov. 30, 2008 | 67,265,500 | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -210,712 | -210,712 |
Ending Balance, Value at Nov. 30, 2009 | 6,727 | 1,346,502 | ' | -1,496,674 | -143,445 |
Beginning Balance, Shares at Nov. 30, 2009 | 67,265,500 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Shares | 396,490 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | 39 | 101,610 | ' | ' | 101,649 |
NET INCOME (LOSS) | ' | ' | ' | -575,562 | -575,562 |
Ending Balance, Value at Nov. 30, 2010 | 6,766 | 1,448,112 | ' | -2,072,236 | -617,358 |
Ending Balance, Shares at Nov. 30, 2010 | 67,661,990 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Shares | 14,411,900 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | 1,441 | 219,678 | ' | ' | 221,119 |
NET INCOME (LOSS) | ' | ' | ' | -1,097,678 | -1,097,678 |
Ending Balance, Value at Nov. 30, 2011 | 8,207 | 1,667,790 | ' | -3,169,914 | -1,493,917 |
Ending Balance, Shares at Nov. 30, 2011 | 82,073,890 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | ' | ' | ' | ' | ' |
Collection on subscription | ' | ' | ' | ' | ' |
NET INCOME (LOSS) | ' | ' | ' | -392,964 | -392,964 |
Ending Balance, Value at Nov. 30, 2012 | 8,207 | 1,667,790 | ' | -3,562,878 | -1,886,881 |
Beginning Balance, Shares at Nov. 30, 2012 | 82,073,890 | ' | ' | ' | ' |
Stock issued for equipment purchase, Shares | 70,000,000 | ' | ' | ' | ' |
Stock issued for equipment purchase, Value | 7,000 | 693,000 | ' | ' | 700,000 |
Stock issued in exchange for professional fees, Shares | 12,400,000 | ' | ' | ' | ' |
Stock issued in exchange for professional fees, Value | 1,240 | 434,760 | ' | ' | 436,000 |
NET INCOME (LOSS) | ' | ' | ' | -535,686 | -535,686 |
Ending Balance, Value at Nov. 30, 2013 | $16,447 | $2,795,550 | ' | ($4,098,564) | ($1,286,567) |
Ending Balance, Shares at Nov. 30, 2013 | 164,473,890 | ' | ' | ' | ' |
NOTE_1_ORGANIZATION_AND_DESCRI
NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS | 12 Months Ended |
Nov. 30, 2013 | |
Accounting Policies [Abstract] | ' |
1. ORGANIZATION AND DESCRIPTION OF BUSINESS | ' |
NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS | |
PURTHANOL RESOURCES LIMITED (formerly GLOBAL BIOTECH CORP.) (the ``Company``) was incorporated in the State of Delaware on November 2, 1998 to be an Application Service provider in the E-Health sector. On March 5, 2003 this business was sold, market, unsuccessfully. On February 25, 2005 it discontinued its vehicle tracking business. On August 15, 2007 the Company entered the oxygenated beverage market. Global’s current mission is to use the Purthonal process methodology, acquired in October 2013, to produce an ethanol fuel alternative. The Company changed name form Global Biotech Corp. to Purthanol Resources Limited on September 30, 2013 |
NOTE_2_SUMMARY_OF_SIGNIFICANT_
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended | ||
Nov. 30, 2013 | |||
Accounting Policies [Abstract] | ' | ||
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | ||
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |||
a. Accounting Method | |||
The Company's policy is to use the accrual method of accounting to prepare and present financial statements, which conforms to US generally accepted accounting principles ("GAAP'). The company has elected a November 30 year- end. | |||
b. Cash and Cash Equivalents | |||
The Company considers all highly liquid investments with original maturities of three months or less and bank indebtedness to be cash and cash equivalents. Highly liquid investments are valued at quoted market prices. | |||
c. Estimates and Adjustments | |||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from those estimates. | |||
Significant estimates made by management are, among others, realizability of long-lived assets, and deferred taxes. Management reviews its estimates on a quarterly basis and, where necessary, makes adjustments prospectively. | |||
d. Basis of Presentation and Considerations Related to Continued Existence (going concern) | |||
The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. | |||
The Company's management intends to raise additional operating funds through operations, and debt or equity offerings. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings. | |||
e. Fair Value of Financial Instruments | |||
ASC 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. | |||
Fair Value Hierarchy | |||
ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value: | |||
Level 1 applies to assets and liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment. | |||
Level 2 applies to assets and liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. | |||
Level 2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: | |||
• Determining which instruments are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced; and | |||
• Determining whether a market is considered active requires management judgment. | |||
Level 3 applies to assets and liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of | |||
The Company believes the fair value of its financial instruments consisting of cash, short term investment, and accounts payable approximate their carrying values due to the relatively short maturity of these instruments. | |||
f. Property & Equipment | |||
Property is stated at cost. Additions, renovations, and improvements are capitalized. Maintenance and repairs, which do not extend asset lives, are expensed as incurred. | |||
g. Depreciation | |||
Depreciation is provided on a straight-line basis over the estimated useful lives, 5 years for tenant improvements, and 5 - 7 years for equipment. | |||
h. Impairment of Long-Lived Assets | |||
Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the estimated undiscounted cash flows, expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of such assets. | |||
i. Revenue Recognition and Deferred Revenue | |||
The Company's revenues recognized from inception to November 30, 2013 were software consultation. Revenue, in respect of all services described, is recognized on completion of services, when collectability is reasonably assured. | |||
j. Foreign Currency Exchange | |||
We record our transactions in US dollars. | |||
Foreign currency accounts have been translated as follows: | |||
• | Monetary items - at exchange rates in effect at the balance sheet date | ||
• | Non-monetary item - at exchange rates in effect of the dates of transactions | ||
• | Revenue and expenses - at average exchange rate prevailing during the year. | ||
Gains and losses arising from foreign currency translation are included in income. | |||
k. Earning (Loss) Per Share | |||
The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC 260 effective November 2, 1998 (inception). | |||
Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. | |||
l. Stock-Based Compensation | |||
The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Based Compensation, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. | |||
m. Convertible Debt | |||
In accordance with Codifications topic 470 ”Debt with conversion and Other Options” the Company evaluates debt securities (“Debt”) for beneficial conversion features. A beneficial conversion feature is present when the conversion price per share is less than the market value of the common stock at the commitment date. The intrinsic value of the feature is then measured as the difference between the conversion price and the market value (the “Spread”) multiplied by the number of shares into which the Debt is convertible and is recorded as debt discount with an offsetting amount increasing additional paid-in-capital. The debt discount is accreted to interest expense over the term of the Debt with any unamortized discount recognized as interest expense upon conversion of the Debt. If a debt security contains terms that change upon the occurrence of a future event the incremental intrinsic value is measured as the additional number of issuable shares multiplied by the commitment date market value and is recognized as additional debt discount with an offsetting amount increasing additional paid-in-capital upon the future event occurrence. The total intrinsic value of the feature is limited to the proceeds allocated to the Debt instrument. | |||
n. Recent Accounting Pronouncements | |||
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
NOTE_3_GOING_CONCERN
NOTE 3. GOING CONCERN | 12 Months Ended |
Nov. 30, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
3. GOING CONCERN | ' |
NOTE 3. GOING CONCERN | |
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company generated net losses of $535,686 for the year ended November 30, 2013 and a net loss of $4,098,564 during the period from November 2, 1998 (inception) through November 30, 2013. At November 30, 2013 the Company had negative working capital of $1,986,567 and stockholders’ deficit of $1,286,567. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. | |
The officers and directors are committed to help in raising funds to fill any operating cash flow shortages during the next fiscal year until the organization can generate sufficient funds from operations to meet current operating expenses and overhead, although there are no guarantees that this commitment will be met. |
NOTE_4_SHORT_TERM_INVESTMENTS
NOTE 4. SHORT TERM INVESTMENTS | 12 Months Ended |
Nov. 30, 2013 | |
Summary of Investments, Other than Investments in Related Parties [Abstract] | ' |
4. SHORT TERM INVESTMENTS | ' |
NOTE 4. SHORT TERM INVESTMENTS | |
On November 6, 2010, the Company purchased a term deposit in the amount of $163,400 USD, ($172,000CDN) bearing interest rate of 5%. On November 6, 2013 they extended the maturity date to November 6, 2014. As of November 30, 2013 the Company accrued $34,048 USD of interest income. No withdrawals allowed for first 90 days and 90 days early withdrawal notice needed. Early withdrawal interest rate - 1 ½%. |
NOTE_5_PROPERTY_EQUIPMENT
NOTE 5. PROPERTY & EQUIPMENT | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
5. PROPERTY & EQUIPMENT | ' | ||||||||
NOTE 5. PROPERTY & EQUIPMENT | |||||||||
On August 15, 2007 the Company acquired Oxygenation Equipment with a cost of $605,000 in exchange for common shares. | |||||||||
30-Nov-13 | 30-Nov-12 | ||||||||
Oxygenation Equipment | $ | 605,000 | $ | 605,000 | |||||
Less: Impairment Loss | 605,000 | 518,570 | |||||||
Net Property and Equipment | $ | 0 | $ | 86,430 | |||||
Company recognized impairment losses of $86,430 and $86,428 for the years ended November 30, 2013 and 2012, respectively. |
NOTE_6_INTANGIBLE_ASSETS
NOTE 6. INTANGIBLE ASSETS | 12 Months Ended |
Nov. 30, 2013 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ' |
6. INTANGIBLE ASSETS | ' |
NOTE 6. INTANGIBLE ASSETS | |
On September 10, 2013 the Company acquired all the intellectual property, process know-how and methodology, etc. for the production of Athanol (the name used by Purthanol International for its green- technology ethanol fuel alternative), or any other ethanol fuel alternative produced via the Purthanol Process. | |
The cost of the above transaction, $700,000, was paid by Purthanol issuing from its treasury seventy million (70 million) common shares. |
NOTE_7_BASIC_DILUTED_INCOME_LO
NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE | ' | ||||||||
NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE | |||||||||
Basic gain (loss) per common share has been calculated based on the weighted average number of shares of common stock outstanding during the period. Diluted gain (loss) per common share has been calculated based on the weighted average number of shares of common and preferred stock outstanding during the period. | |||||||||
30-Nov-13 | 30-Nov-12 | ||||||||
Net income (Loss) from operations | $ | (535,686 | ) | $ | (392,964 | ) | |||
Basic income / (loss) per share | $ | (0.00 | ) | $ | (0.00 | ) | |||
Weighted average number of shares outstanding | 99,842,657 | 82,073,890 |
NOTE_8_NOTES_PAYABLE
NOTE 8. NOTES PAYABLE | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
8. NOTES PAYABLE | ' | ||||||||
NOTE 8. NOTES PAYABLE | |||||||||
Note payable as of November 30, 2013 and 2012 consist of the following: | |||||||||
2013 | 2012 | ||||||||
Note payable to: Millenia Hope Inc. unsecured, with annual interest rate 7%. | $ | 652,110 | $ | 608,392 | |||||
Third parties, unsecured with annual interest of 4%, commencing July 1, 2009 | 105,063 | 107,063 | |||||||
Convertible note payable to third parties with annual interest of 2%, commencing March 1, 2011 Loan is convertible to common shares of Global Biotech at par to the lowest daily trading price of the shares on the conversion request date | 205,319 | 213,612 | |||||||
Convertible note payble to third parties with annual interest of 8%, commencing April 30, 2009 Loan is convertible to common shares of Global Biotech at the lesser of $1.00 per share or the average closing price of the shares for the 5 business days prior to conversion | 323,739 | 319,089 | |||||||
$ | 1,286,231 | $ | 1,248,156 | ||||||
Included in the Notes payable is Millenia Hope due $652,110, who had a common officer with the company, Leonard Stella. | |||||||||
There are no beneficial conversion features because the Company has conversion right. |
NOTE_9_LICENSING_RIGHTS
NOTE 9. LICENSING RIGHTS | 12 Months Ended |
Nov. 30, 2013 | |
Accounting Policies [Abstract] | ' |
9. LICENSING RIGHTS | ' |
NOTE 9. LICENSING RIGHTS | |
On October 11, 2013, Purthanol Quebec, an arm’s length corporation, acquired from the Company the rights to use the Purthanol Process to extract ethanol, in the Province of Quebec, Canada for $312,200. All sales of said extracted ethanol are to be done through Purthanol Resources and the gross profit on these sales, less standard distribution and delivery costs, will be split on a 50-50 basis between the 2 companies. The Company recognized $312,200 as revenue. |
NOTE_10_INCOME_TAXES
NOTE 10. INCOME TAXES | 12 Months Ended | ||||
Nov. 30, 2013 | |||||
Income Tax Disclosure [Abstract] | ' | ||||
10. INCOME TAXES | ' | ||||
NOTE 10. INCOME TAXES | |||||
Income taxes are provided in accordance with ASC 740, Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carry-forwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities. | |||||
The net operating loss expires twenty years from the date the loss was incurred. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. | |||||
No portion of the valuation allowance will be allocated to reduce goodwill or other non-current intangible asset of an acquired entity. There are no temporary differences or carry-forward tax effects that would significantly effect the Companies deferred tax asset. | |||||
Utilization of the net operating losses and credit carry-forwards may be subject to a substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986. The annual limitation may result in the expiration of net operating losses and credits before utilization. At November 30, 2013 the Company had net operating losses carry-forward of $4,098,564. The tax benefits resulting for these losses have been estimated as follows: | |||||
30-Nov-13 | |||||
Gross income tax benefit | $ | 1,434,000 | |||
Valuation Allowance | 1,434,000 | ||||
Net Income Tax Benefit | $ | 0 | |||
Deficit - December 1, 2012 | $ | (3,562,878 | ) | ||
Net Loss for Year ended November 30, 2013 | (535,686 | ) | |||
Deficit - November 30, 2013 | $ | (4,098,564 | ) | ||
NOTE_11_STOCK_TRANSACTIONS
NOTE 11. STOCK TRANSACTIONS | 12 Months Ended |
Nov. 30, 2013 | |
Notes to Financial Statements | ' |
11. STOCK TRANSACTIONS | ' |
NOTE 11. STOCK TRANSACTIONS | |
On September 10, 2013 the Company issued 70,000,000 common shares in settlement of property and equipment of $700,000. | |
On September 23, 2013 the Company issued 2,400,000 common shares in settlement of consulting fees of $36,000 | |
On October 4, 2013 the Company issued 10,000,000 common shares in settlement of consulting fees of $400,000 | |
As of November 30, 2013 the Company had 164,473,890 shares of common stock issued and outstanding |
NOTE_12_STOCKHOLDERS_EQUITY
NOTE 12. STOCKHOLDERS EQUITY | 12 Months Ended |
Nov. 30, 2013 | |
Equity [Abstract] | ' |
12. STOCKHOLDERS EQUITY | ' |
NOTE 12. STOCKHOLDERS' EQUITY | |
The stockholders' equity section of the Company contains the following classes of capital stock as of November 30, 2013 and 2012: | |
Common stock, $ 0.0001 par value; 260,000,000 shares and 260,000,000 shares authorized November 30, 2012 and 2013: 82,073,890 shares issued and outstanding as of November 30, 2012 and 164,473,890 as of November 30, 2013. | |
Preferred Stock, $0.0001 par value; 80,000,000 shares authorized as November 30, 2012 and November 30, 2013. Zero (0) shares issued and outstanding, as of November 30, 2012 and 2013. |
NOTE_13_RELATED_PARTY_TRANSACT
NOTE 13. RELATED PARTY TRANSACTIONS | 12 Months Ended |
Nov. 30, 2013 | |
Related Party Transactions [Abstract] | ' |
13. RELATED PARTY TRANSACTIONS | ' |
NOTE 13. RELATED PARTY TRANSACTIONS | |
As of November 30, 2013 the Company owed two of its officers, Leonard Stella, CEO, and Yehuda Kops, CFO, $846,362 of administrative fees. This amount is included in the Accounts payable. | |
The Notes payable related is due to its former President, Louis Greco. |
NOTE_14_SUBSEQUENT_EVENTS
NOTE 14. SUBSEQUENT EVENTS | 12 Months Ended |
Nov. 30, 2013 | |
Subsequent Events [Abstract] | ' |
14. SUBSEQUENT EVENTS | ' |
NOTE 14. SUBSEQUENT EVENTS | |
In accordance with ASC 855, Subsequent Events, the Company has evaluated subsequent events through the date of issuance of the audited financial statements. During this period, the Company had the following subsequent event. | |
On December 16, 2013, Global acquired 100% of all outstanding shares of Biocardel Quebec, a privately held company, for $5 million, payable $100,000 at signing of the agreement, $2,400,000 in 9 months, as a balance of sale and $2,500,000 in preferred convertible shares, at a 25% discount to the 90 trading -day average sales price of the common shares, whenever Global chooses to exercise the conversion rights. Biocardel owns a production facility in Richmond, Quebec, that turns biologic oil waste products and byproducts into biodiesel fuel, a commodity in demand in both North America and Europe. | |
On February 25, 2014 the Company issued 650,000 common shares in settlement of consulting fees of $9,750. |
NOTE_2_SUMMARY_OF_SIGNIFICANT_1
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended | ||
Nov. 30, 2013 | |||
Accounting Policies [Abstract] | ' | ||
a. Accounting Method | ' | ||
a. Accounting Method | |||
The Company's policy is to use the accrual method of accounting to prepare and present financial statements, which conforms to US generally accepted accounting principles ("GAAP'). The company has elected a November 30 year- end. | |||
b. Cash and Cash Equivalents | ' | ||
b. Cash and Cash Equivalents | |||
The Company considers all highly liquid investments with original maturities of three months or less and bank indebtedness to be cash and cash equivalents. Highly liquid investments are valued at quoted market prices. | |||
c. Estimates and Adjustments | ' | ||
c. Estimates and Adjustments | |||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from those estimates. | |||
Significant estimates made by management are, among others, realizability of long-lived assets, and deferred taxes. Management reviews its estimates on a quarterly basis and, where necessary, makes adjustments prospectively. | |||
d. Basis of Presentation and Considerations Related to Continued Existence (going concern) | ' | ||
d. Basis of Presentation and Considerations Related to Continued Existence (going concern) | |||
The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. | |||
The Company's management intends to raise additional operating funds through operations, and debt or equity offerings. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings. | |||
e. Fair Value of Financial Instruments | ' | ||
e. Fair Value of Financial Instruments | |||
ASC 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. | |||
Fair Value Hierarchy | |||
ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value: | |||
Level 1 applies to assets and liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment. | |||
Level 2 applies to assets and liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. | |||
Level 2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: | |||
• Determining which instruments are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced; and | |||
• Determining whether a market is considered active requires management judgment. | |||
Level 3 applies to assets and liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of | |||
The Company believes the fair value of its financial instruments consisting of cash, short term investment, and accounts payable approximate their carrying values due to the relatively short maturity of these instruments. | |||
f. Property & Equipment | ' | ||
f. Property & Equipment | |||
Property is stated at cost. Additions, renovations, and improvements are capitalized. Maintenance and repairs, which do not extend asset lives, are expensed as incurred. | |||
g. Depreciation | ' | ||
g. Depreciation | |||
Depreciation is provided on a straight-line basis over the estimated useful lives, 5 years for tenant improvements, and 5 - 7 years for equipment. | |||
h. Impairment of Long-Lived Assets | ' | ||
h. Impairment of Long-Lived Assets | |||
Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the estimated undiscounted cash flows, expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of such assets. | |||
i. Revenue Recognition and Deferred Revenue | ' | ||
i. Revenue Recognition and Deferred Revenue | |||
The Company's revenues recognized from inception to November 30, 2013 were software consultation. Revenue, in respect of all services described, is recognized on completion of services, when collectability is reasonably assured. | |||
j. Foreign Currency Exchange | ' | ||
j. Foreign Currency Exchange | |||
We record our transactions in US dollars. | |||
Foreign currency accounts have been translated as follows: | |||
• | Monetary items - at exchange rates in effect at the balance sheet date | ||
• | Non-monetary item - at exchange rates in effect of the dates of transactions | ||
• | Revenue and expenses - at average exchange rate prevailing during the year. | ||
Gains and losses arising from foreign currency translation are included in income. | |||
k. Earning (Loss) Per Share | ' | ||
k. Earning (Loss) Per Share | |||
The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC 260 effective November 2, 1998 (inception). | |||
Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. | |||
l. Stock-Based Compensation | ' | ||
l. Stock-Based Compensation | |||
The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Based Compensation, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. | |||
m. Convertible Debt | ' | ||
m. Convertible Debt | |||
In accordance with Codifications topic 470 ”Debt with conversion and Other Options” the Company evaluates debt securities (“Debt”) for beneficial conversion features. A beneficial conversion feature is present when the conversion price per share is less than the market value of the common stock at the commitment date. The intrinsic value of the feature is then measured as the difference between the conversion price and the market value (the “Spread”) multiplied by the number of shares into which the Debt is convertible and is recorded as debt discount with an offsetting amount increasing additional paid-in-capital. The debt discount is accreted to interest expense over the term of the Debt with any unamortized discount recognized as interest expense upon conversion of the Debt. If a debt security contains terms that change upon the occurrence of a future event the incremental intrinsic value is measured as the additional number of issuable shares multiplied by the commitment date market value and is recognized as additional debt discount with an offsetting amount increasing additional paid-in-capital upon the future event occurrence. The total intrinsic value of the feature is limited to the proceeds allocated to the Debt instrument. | |||
n. Recent Accounting Pronouncements | ' | ||
n. Recent Accounting Pronouncements | |||
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
NOTE_5_PROPERTY_EQUIPMENT_Tabl
NOTE 5. PROPERTY & EQUIPMENT (Tables) | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property and Equipment | ' | ||||||||
30-Nov-13 | 30-Nov-12 | ||||||||
Oxygenation Equipment | $ | 605,000 | $ | 605,000 | |||||
Less: Impairment Loss | 605,000 | 518,570 | |||||||
Net Property and Equipment | $ | 0 | $ | 86,430 |
NOTE_7_BASIC_DILUTED_INCOME_LO1
NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE (Tables) | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Basic and Diluted Income / (Loss) Per Common Share | ' | ||||||||
30-Nov-13 | 30-Nov-12 | ||||||||
Net income (Loss) from operations | $ | (535,686 | ) | $ | (392,964 | ) | |||
Basic income / (loss) per share | $ | (0.00 | ) | $ | (0.00 | ) | |||
Weighted average number of shares outstanding | 99,842,657 | 82,073,890 |
NOTE_8_NOTES_PAYABLE_Tables
NOTE 8. NOTES PAYABLE (Tables) | 12 Months Ended | ||||||||
Nov. 30, 2013 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
Notes Payable | ' | ||||||||
2013 | 2012 | ||||||||
Note payable to: Millenia Hope Inc. unsecured, with annual interest rate 7%. | $ | 652,110 | $ | 608,392 | |||||
Third parties, unsecured with annual interest of 4%, commencing July 1, 2009 | 105,063 | 107,063 | |||||||
Convertible note payable to third parties with annual interest of 2%, commencing March 1, 2011 Loan is convertible to common shares of Global Biotech at par to the lowest daily trading price of the shares on the conversion request date | 205,319 | 213,612 | |||||||
Convertible note payble to third parties with annual interest of 8%, commencing April 30, 2009 Loan is convertible to common shares of Global Biotech at the lesser of $1.00 per share or the average closing price of the shares for the 5 business days prior to conversion | 323,739 | 319,089 | |||||||
$ | 1,286,231 | $ | 1,248,156 |
NOTE_10_INCOME_TAXES_Tables
NOTE 10. INCOME TAXES (Tables) | 12 Months Ended | ||||
Nov. 30, 2013 | |||||
Income Tax Disclosure [Abstract] | ' | ||||
Income Tax Benefits | ' | ||||
30-Nov-13 | |||||
Gross income tax benefit | $ | 1,434,000 | |||
Valuation Allowance | 1,434,000 | ||||
Net Income Tax Benefit | $ | 0 | |||
Deficit - December 1, 2012 | $ | (3,562,878 | ) | ||
Net Loss for Year ended November 30, 2013 | (535,686 | ) | |||
Deficit - November 30, 2013 | $ | (4,098,564 | ) |
NOTE_3_GOING_CONCERN_Details_N
NOTE 3. GOING CONCERN (Details Narrative) (USD $) | 12 Months Ended | 24 Months Ended | 181 Months Ended | |||||||||||||
Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2011 | Nov. 30, 2010 | Nov. 30, 2009 | Nov. 30, 2008 | Nov. 30, 2007 | Nov. 30, 2006 | Nov. 30, 2005 | Nov. 30, 2004 | Nov. 30, 2003 | Nov. 30, 2002 | Nov. 30, 2001 | Nov. 30, 2000 | Nov. 30, 2013 | Nov. 30, 1998 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
NET INCOME (LOSS) | ($535,686) | ($392,964) | ($1,097,678) | ($575,562) | ($210,712) | ($63,371) | ($376,336) | ($47,203) | $142,417 | ($12,936) | ($715,903) | ($141,693) | ($1,679) | ($69,231) | ($4,098,564) | ' |
Working Capital | -1,986,567 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -1,986,567 | ' |
Stockholders Equity | ($1,286,567) | ($1,886,881) | ($1,493,917) | ($617,358) | ($143,445) | $67,267 | $130,638 | ($213,026) | ($166,823) | ($309,240) | ($296,277) | $261,751 | $333,569 | $335,248 | ($1,286,567) | ' |
NOTE_4_SHORT_TERM_INVESTMENTS_
NOTE 4. SHORT TERM INVESTMENTS (Details Narrative) (USD $) | Nov. 30, 2013 | Nov. 06, 2010 |
Term Deposit | ' | $163,400 |
Term Deposit, Interest Rate | ' | 500.00% |
Term Deposit, Accrued Interest Income | 34,048 | ' |
Term Deposit, Early Withdrawal Interest Rate | ' | 1.50% |
Canada, Dollars | ' | ' |
Term Deposit | ' | ($172,000) |
NOTE_5_PROPERTY_EQUIPMENT_Prop
NOTE 5. PROPERTY & EQUIPMENT - Property and Equipment (Details) (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
Property, Plant and Equipment [Abstract] | ' | ' |
Oxygenation equipment | $605,000 | $605,000 |
Less: Impairment Loss | 605,000 | 518,570 |
Net Property and Equipment | ' | $86,430 |
NOTE_5_PROPERTY_EQUIPMENT_Deta
NOTE 5. PROPERTY & EQUIPMENT (Details Narrative) (USD $) | 12 Months Ended | 181 Months Ended | ||
Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2007 | Nov. 30, 2013 | |
Property, Plant and Equipment [Abstract] | ' | ' | ' | ' |
Property and Equipment, Cost of Acquisition | ' | ' | $605,000 | ' |
Impairment Losses | $132,138 | $86,428 | ' | $981,969 |
NOTE_6_INTANGIBLE_ASSETS_Detai
NOTE 6. INTANGIBLE ASSETS (Details Narrative) (USD $) | 12 Months Ended | 181 Months Ended |
Nov. 30, 2013 | Nov. 30, 2013 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ' |
Cost to Acquire Intangible Assets, Value | $700,000 | $700,000 |
Cost to Acquire Intangible Assets, Shares | 70,000,000 | ' |
NOTE_7_BASIC_DILUTED_INCOME_LO2
NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE - Basic and Diluted Income / (Loss) Per Common Share (Details) (USD $) | 12 Months Ended | |
Nov. 30, 2013 | Nov. 30, 2012 | |
Earnings Per Share [Abstract] | ' | ' |
Net income (loss) from operations | ($535,686) | ($392,964) |
Basic income / (loss) per share | $0 | $0 |
Weighed average number of shares outstanding | 99,842,657 | 82,073,890 |
NOTE_8_NOTES_PAYABLE_Notes_Pay
NOTE 8. NOTES PAYABLE - Notes Payable (Details) (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
Notes Payable | $1,286,231 | $1,248,156 |
Millenia Hope [Member] | ' | ' |
Notes Payable | 652,110 | 608,392 |
Third Parties, Unsecured | ' | ' |
Notes Payable | 105,063 | 107,063 |
Convertible Note, Third Parties 1 | ' | ' |
Notes Payable | 205,319 | 213,612 |
Convertible Note, Third Parties 2 | ' | ' |
Notes Payable | $323,739 | $319,089 |
NOTE_8_NOTES_PAYABLE_Details_N
NOTE 8. NOTES PAYABLE (Details Narrative) (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
Note Payable - Related Party | $45,244 | $46,352 |
Millenia Hope [Member] | ' | ' |
Note Payable - Related Party | $652,110 | ' |
NOTE_9_LICENSING_RIGHTS_Detail
NOTE 9. LICENSING RIGHTS (Details Narrative) (USD $) | 12 Months Ended |
Nov. 30, 2013 | |
Accounting Policies [Abstract] | ' |
Revenue from Sale of Rights | $312,200 |
NOTE_10_INCOME_TAXES_Income_Ta
NOTE 10. INCOME TAXES - Income Tax Benefits (Details) (USD $) | 12 Months Ended | 24 Months Ended | 181 Months Ended | ||||||||||||
Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2011 | Nov. 30, 2010 | Nov. 30, 2009 | Nov. 30, 2008 | Nov. 30, 2007 | Nov. 30, 2006 | Nov. 30, 2005 | Nov. 30, 2004 | Nov. 30, 2003 | Nov. 30, 2002 | Nov. 30, 2001 | Nov. 30, 2000 | Nov. 30, 2013 | |
Income Tax Disclosure [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Gross income tax benefit | $1,434,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Valuation Allowance | 1,434,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net Income Tax Benefit | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deficit - December 1, 2012 | -3,562,878 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
NET INCOME (LOSS) | -535,686 | -392,964 | -1,097,678 | -575,562 | -210,712 | -63,371 | -376,336 | -47,203 | 142,417 | -12,936 | -715,903 | -141,693 | -1,679 | -69,231 | -4,098,564 |
Deficit - November 30, 2013 | ($4,098,564) | ($3,562,878) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ($4,098,564) |
NOTE_10_INCOME_TAXES_Details_N
NOTE 10. INCOME TAXES (Details Narrative) (USD $) | Nov. 30, 2013 |
Income Tax Disclosure [Abstract] | ' |
Net Operating Loss Carry-Forward | $4,098,564 |
NOTE_11_STOCK_TRANSACTIONS_Det
NOTE 11. STOCK TRANSACTIONS (Details Narrative) (USD $) | 1 Months Ended | 9 Months Ended | 12 Months Ended | 24 Months Ended | ||||
Oct. 31, 2013 | Sep. 30, 2013 | Aug. 30, 2014 | Nov. 30, 2013 | Nov. 30, 2007 | Nov. 30, 2002 | Nov. 30, 2000 | Nov. 30, 2012 | |
Notes to Financial Statements | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued for Purchase of Property and Equipment, Shares | ' | 70,000,000 | ' | ' | ' | ' | ' | ' |
Stock Issued for Purchase of Property and Equipment, Value | ' | $700,000 | ' | $700,000 | $720,000 | ' | $15,000 | ' |
Stock issued for payment of consulting fees, Shares | 10,000,000 | 2,400,000 | 650,000 | ' | ' | ' | ' | ' |
Stock issued for payment of consulting fees, Value | $400,000 | $36,000 | $9,750 | ' | ' | $18,500 | ' | ' |
Common Stock, Shares Issued | ' | ' | ' | 164,473,890 | ' | ' | ' | 82,073,890 |
Common Stock, Shares Outstanding | ' | ' | ' | 164,473,890 | ' | ' | ' | 82,073,890 |
NOTE_12_STOCKHOLDERS_EQUITY_De
NOTE 12. STOCKHOLDERS EQUITY (Details Narrative) (USD $) | Nov. 30, 2013 | Nov. 30, 2012 |
Equity [Abstract] | ' | ' |
Preferred stock authorized shares | 80,000,000 | 80,000,000 |
Preferred stock par value shares | $0.00 | $0.00 |
Preferred stock shares issued | 0 | 0 |
Preferred stock shares outstanding | 0 | 0 |
Common stock authorized shares | 260,000,000 | 260,000,000 |
Common stock par value shares | $0.00 | $0.00 |
Common stock shares issued | 164,473,890 | 82,073,890 |
Common stock shares outstanding | 164,473,890 | 82,073,890 |
NOTE_13_RELATED_PARTY_TRANSACT1
NOTE 13. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $) | 12 Months Ended |
Nov. 30, 2013 | |
Related Party Transactions [Abstract] | ' |
Administrative Fees | $846,362 |
NOTE_14_SUBSEQUENT_EVENTS_Deta
NOTE 14. SUBSEQUENT EVENTS (Details Narrative) (USD $) | 1 Months Ended | 9 Months Ended | 12 Months Ended | 24 Months Ended | ||
Dec. 31, 2013 | Oct. 31, 2013 | Sep. 30, 2013 | Aug. 30, 2014 | Nov. 30, 2002 | Nov. 30, 2000 | |
Subsequent Events [Abstract] | ' | ' | ' | ' | ' | ' |
Percentage of Ownership Acquired | 100.00% | ' | ' | ' | ' | ' |
Acquisition Costs | $5 | ' | ' | ' | ' | ' |
Acquisition Payments | 100,000 | ' | ' | 2,400,000 | ' | ' |
Stock issued for payment of consulting fees, Shares | ' | 10,000,000 | 2,400,000 | 650,000 | ' | ' |
Stock issued for payment of consulting fees, Value | ' | 400,000 | 36,000 | 9,750 | 18,500 | ' |
Stock issued for acquisition, Value | ' | ' | ' | $2,500,000 | ' | $129,478 |